Fujian Cosunter Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2023: -2.56%

Fujian Cosunter Pharmaceutical Co Ltd (300436) has an Asset Resilience Ratio of -2.56% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Fujian Cosunter Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥-43.49 Million

≈ $-6.36 Million USD Cash + Short-term Investments

Total Assets

CN¥1.70 Billion

≈ $248.30 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2016)

This chart shows how Fujian Cosunter Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 300436 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Fujian Cosunter Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Fujian Cosunter Pharmaceutical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-43.49 Million	-2.56%
Total Liquid Assets	CN¥-43.49 Million	-2.56%

Asset Resilience Insights

Limited Liquidity: Fujian Cosunter Pharmaceutical Co Ltd maintains only -2.56% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Fujian Cosunter Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Fujian Cosunter Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Cipla Limited NSE:CIPLA	Drug Manufacturers - Specialty & Generic	20.75%
Alkem Laboratories Limited NSE:ALKEM	Drug Manufacturers - Specialty & Generic	31.91%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.92%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	11.00%

Annual Asset Resilience Ratio for Fujian Cosunter Pharmaceutical Co Ltd (2015–2016)

The table below shows the annual Asset Resilience Ratio data for Fujian Cosunter Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2016-12-31	7.14%	CN¥50.00 Million ≈ $7.32 Million	CN¥700.67 Million ≈ $102.53 Million	-42.81pp
2015-12-31	49.94%	CN¥300.00 Million ≈ $43.90 Million	CN¥600.70 Million ≈ $87.90 Million	--

pp = percentage points

About Fujian Cosunter Pharmaceutical Co Ltd

SHE:300436 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.74 Billion

CN¥18.71 Billion CNY

Market Cap Rank

#5338 Global

#1047 in China

Share Price

CN¥117.50

Change (1 day)

-2.87%

52-Week Range

CN¥28.25 - CN¥172.22

All Time High

CN¥172.22